Login / Signup

Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer.

Feng WangMing-Ming HeZi-Xian WangSu LiYing JinChao RenSi-Mei ShiBing-Tian BiShuang-Zhen ChenZhi-Da LvJia-Jia HuZhi-Qiang WangFeng-Hua WangDe-Shen WangYu-Hong LiRui-Hua Xu
Published in: BMC cancer (2019)
ClinicalTrial.gov Identifier: NCT02969681 .
Keyphrases
  • metastatic colorectal cancer
  • high dose
  • low dose
  • stem cell transplantation
  • randomized controlled trial
  • clinical trial
  • squamous cell carcinoma
  • radiation therapy
  • study protocol
  • double blind